Literature DB >> 23600691

Molecular level activation insights from a NR2A/NR2B agonist.

Weng Ieong Tou1, Su-Sen Chang, Dongchuan Wu, Ted Weita Lai, Yu Tian Wang, Chung Y Hsu, Calvin Yu-Chian Chen.   

Abstract

N-methyl D-aspartate receptors (NMDARs), a subclass of glutamate receptors have broad actions in neural transmission for major brain functions. Overactivation of NMDARs leading to "excitotoxicity" is the underlying mechanism of neuronal death in a number of neurological diseases, especially stroke. Much research effort has been directed toward developing pharmacological agents to modulate NMDAR actions for treating neurological diseases, in particular stroke. Here, we report that Alliin, a sulfoxide in fresh garlic, exhibits affinity toward NR2A as well as NR2B receptors based on virtual screening. Biological activities of Alliin on these two receptors were confirmed in electrophysiological studies. Ligand-binding site closure, a structural change precluding ion channel opening, was observed with Alliin during 100 ns molecular dynamics simulation. Alliin interactions with NR2A and NR2B suggest that residues E/A413, H485, T690, and Y730 may play important roles in the conformation shift. Activation of NR2A and NR2B by Alliin can be differentiated from that caused by glutamate, the endogenous neurotransmitter. These characteristic molecular features in NR2A and NR2B activation provide insight into structural requirements for future development of novel drugs with selective interaction with NR2A and NR2B for treating neurological diseases, particularly stroke.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23600691     DOI: 10.1080/07391102.2013.787371

Source DB:  PubMed          Journal:  J Biomol Struct Dyn        ISSN: 0739-1102


  4 in total

1.  Treatment of acute lymphoblastic leukemia from traditional chinese medicine.

Authors:  Ya-Li Hsiao; Pei-Chun Chang; Hung-Jin Huang; Chia-Chen Kuo; Calvin Yu-Chian Chen
Journal:  Evid Based Complement Alternat Med       Date:  2014-05-22       Impact factor: 2.629

2.  Potential smoothened inhibitor from traditional Chinese medicine against the disease of diabetes, obesity, and cancer.

Authors:  Kuan-Chung Chen; Mao-Feng Sun; Hsin-Yi Chen; Cheng-Chun Lee; Calvin Yu-Chian Chen
Journal:  Biomed Res Int       Date:  2014-07-01       Impact factor: 3.411

3.  Altered Levels of Zinc and N-methyl-D-aspartic Acid Receptor Underlying Multiple Organ Dysfunctions After Severe Trauma.

Authors:  Guanghuan Wang; Xiaojun Yu; Dian Wang; Xiaohu Xu; Guang Chen; Xuewu Jiang
Journal:  Med Sci Monit       Date:  2015-09-03

4.  Potential retinoid x receptor agonists for treating Alzheimer's disease from traditional chinese medicine.

Authors:  Kuan-Chung Chen; Yu-Cheng Liu; Cheng-Chun Lee; Calvin Yu-Chian Chen
Journal:  Evid Based Complement Alternat Med       Date:  2014-04-30       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.